The global hyaluronic acid products market is expected to value USD 14.08 billion by 2026 from USD 9.24 billion in 2021, witnessing a CAGR of 8.8% during the forecast period.
Hyaluronic acid is the most commonly used material in cosmetics surgery and skincare as it can act as dermal fillers. These are used for the treatment for mouth sores, dry eyes, and aging of the skin and are also used as dermal filler n cosmetic surgery.
The growing aging population worldwide is a significant driving the growth for the global hyaluronic acid products market. Additionally, technological advancements and growing demand for cosmetic and anti-aging products are estimated to support hyaluronic acid products' market growth from 2020 to 2025.
Furthermore, new product developments and approvals, growing incidence of chronic diseases, and increasing healthcare expenses are to provide fuel to the market's growth rate. Rising significance for the minimally invasive procedures and increasing awareness levels over health and beauty are further expected to propel the global hyaluronic acid products market.
High costs associated with the products, side effects related to the treatments such as itching, and redness are expected to impact the coming years negatively. Lack of awareness in people regarding the usage of cosmetic and skincare procedures and the shortage of skilled professionals required for treating the patients with the hyaluronic acid products are further estimated to limit the market's growth rate to a small extent.
Market Size Available
2020 to 2026
2021 to 2026
By Product Type, Application and Region
Various Analyses Covered
Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities
North America, Europe, Asia Pacific, Latin America, Middle East and Africa
This research report on the global hyaluronic acid products market has been segmented and sub-segmented based on product type, application, and region.
Hyaluronic Acid Products Market - By Product Type
Based on product type, as of 2019, three cycle injection products occupy a significant share and are expected to retain their position during the forecast period.
Hyaluronic Acid Products Market - By Application
Based on the application, the Osteoarthritis segment is closely competing with the dermal fillers segment for the significant share. There has been a substantial upsurge in Osteoarthritis in recent years. Vesicoureteral Reflux segment is expected to account for substantial revenue in the forecast period because of the increasing demand for a minimum invasive surgical process.
Hyaluronic Acid Products Market - By Region
Regionally, North America holds a significant market share owing primarily to the presence of key manufacturers. The presence of a large aging population, growing demand for the minimum invasive cosmetic surgeries, and favorable reimbursement policies and regulatory approvals for intra-articular hyaluronic acid injections are likely to boost this region's market growth. The U.S is expected to lead the market of this region, followed by Canada.
The European region is next to North America in accounting leading shares in the global hyaluronic acid products market and held for a market share of 27% in 2019. Growing applications of hyaluronic acid for cosmetic and personal care products, increasing customer inclination towards physical appearance that has the necessity for cosmetics and anti-aging products are expanding the market in Europe. The Western European market is also on the rise, trailing the North America market closely. Germany and the UK are together to occupy a market share of about 40% in the European market during the analysis period. Spain and France are the major countries of this region.
Asia-Pacific is expected to have the highest growth rate in the hyaluronic acid products market during the analysis period as of growing awareness regarding hyaluronan applications and its efficiency of the market. Moreover, an increasing number of cosmetic surgeries, increasing the necessity for medical tourism, and advancing healthcare infrastructure in existing countries like India and China are expected to foster the market growth.
Latin America is deemed to have stable, fixed, and considerable growth in the hyaluronic acid products market during the analysis period as of aging population, rising number of patients for osteoporosis and rheumatoid arthritis are some of the leading manufacturers in manufacturing hyaluronic acid products in the region over the historical period.
The Middle East & Africa is expected to witness steady growth in the hyaluronic acid market during the historical period of restricted access and affordable housing. Increasing awareness related to the market which is expected to drive the market during the analysis period.
KEY MARKET PARTICIPANTS:
Notable companies leading the Global Hyaluronic Acid Products Market profiled in this report are Allergan, Sanofi, Ferring B.V., Zimmer Biomet, Fidia Farmceutici, Salix Pharmaceutical, Anika Therapeutics, Seikagaku Corporation, Hoffmann-LA Roche Ltd, Alcon, Inc., Smith & Nephew plc and F.Merz Asthetics, Inc.
RECENT MARKET DEVELOPMENTS:
On January 06, 2020, Anika Therapeutics has agreed to obtain Parcus Medical, a leading sports medicine company, and Arthrosurface.
This agreement with both companies will increase commercial capabilities and infrastructure.
On February 01, 2017, Zimmer Biomet has announced the FDA acceptance for the extended 26-week capability claim for Gel-One hyaluronate for the treatment of pain associated with knee osteoarthritis. Gel-One provides millions of patients the ability up to six months of pain relief with a single injection.
On November 08, 2016, Seikagaku Corporation has announced as it has made a distribution agreement in the US for VISCO-3, which is a hyaluronic acid-based viscosupplement product. It determines three injections for the treatment of knee osteoarthritis with Zimmer Biomet Holdings, Inc. As of increasing the aging population in the US, the enlargement for viscosupplement products is expected continue.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product Type
5.1.2 Single Cycle Injection Products
5.1.3 Three Cycle Injectin Products
5.1.4 Five cycle injection Products
5.1.5 Y-o-Y Growth Analysis, By Product Type
5.1.6 Market Attractiveness Analysis, By Product Type
5.1.7 Market Share Analysis, By Product Type
5.2.4 Dermal Filler
5.2.5 Vesicoureteral Reflux
5.2.5 Y-o-Y Growth Analysis, By Application
5.2.6 Market Attractiveness Analysis, By Application
5.2.7 Market Share Analysis, By Application
5.3 End User
5.3.5 Y-o-Y Growth Analysis, By End User
5.3.6 Market Attractiveness Analysis, By End User
5.3.7 Market Share Analysis, By End User
6. Geographical Analysis
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
126.96.36.199 By Geographical Area
188.8.131.52 By Product Type
184.108.40.206 By Application
220.127.116.11 By End User
6.1.4 Market Attractiveness Analysis
18.104.22.168 By Geographical Area
22.214.171.124 By Product Type
126.96.36.199 By Application
188.8.131.52 By End User
6.1.5 Market Share Analysis
184.108.40.206 By Geographical Area
220.127.116.11 By Product Type
18.104.22.168 By Application
22.214.171.124 By End User
6.2 North America
6.1.2 United States
6.3.6 South Korea
6.5 Latin America
6.4.5 Rest of Latin America
6.6 Middle East & Africa
7. Strategic Analysis
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Zimmer Biomet
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.5 Ferring B.V
8.6 Fidia Farmceutici
8.7 Salix Pharmaceutical
8.8 Anika Therpeutics
8.9 Seikagaku Corporation
8.10 Hoffmann-LA Roche Ltd
8.11 Smith & nephew plc.
8.12 F.Merz Asthetics, inc
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
a) List of Tables
b) List of Figures